Department of Chemistry, Capital Normal University, Beijing 100048, China.
Med Chem. 2012 Mar;8(2):163-73. doi: 10.2174/157340612800493665.
We have previously found that the dithiocarbamate derivatives of quinazolin-4(3H)-one could act as cytotoxic agents against a panel of human tumor cell lines. To investigate the contribution of dithiocarbamate moiety to the cytotoxic activity, three series of novel quinazolin-4(3H)-one derivatives bearing thiocarbamate, thiourea or Nmethyldithiocarbamate side chains were synthesized and tested for their cytotoxic activity against human cancer cell lines A549, MCF-7, HeLa, HT29 and HCT-116 by MTT assay. The results showed that transformation of the dithiocarbamate moiety in lead compound I to thiocarbamate or thiourea led to a decrease or loss of cytotoxic activity. Some N-alkylated analogs of lead compound II preferentially inhibited the proliferation of A549 cells, although their potencies were not improved in comparison with the unalkylated counterparts. The structure-activity relationship obtained in this research will be beneficial for further synthesis and discovery of effective cytotoxic agents.
我们之前发现,喹唑啉-4(3H)-酮的二硫代氨基甲酸盐衍生物可以作为细胞毒性剂针对一组人类肿瘤细胞系发挥作用。为了研究二硫代氨基甲酸盐部分对细胞毒性活性的贡献,我们合成了三个系列的新型带有硫代氨基甲酸盐、硫脲或 N-甲基二硫代氨基甲酸盐侧链的喹唑啉-4(3H)-酮衍生物,并通过 MTT 测定法测试了它们对人癌细胞系 A549、MCF-7、HeLa、HT29 和 HCT-116 的细胞毒性活性。结果表明,将先导化合物 I 中的二硫代氨基甲酸盐部分转化为硫代氨基甲酸盐或硫脲会导致细胞毒性活性降低或丧失。一些先导化合物 II 的 N-烷基化类似物优先抑制 A549 细胞的增殖,尽管与未烷基化的对应物相比,它们的效力没有提高。本研究获得的构效关系将有助于进一步合成和发现有效的细胞毒性剂。